The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11739-020-02406-z.pdf
Reference5 articles.
1. Albini A, Di Guardo G, McClain Noonan D, Lombardo M (2020) The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Intern Emerg Med 19:1–8. https://doi.org/10.1007/s11739-020-02364-6
2. Hoffmann H, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S (2020) Cell 181(2):271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052
3. Gardiner K, Muriel Davisson M (2000) The sequence of human chromosome 21 and implications for research into Down syndrome. Genome Biol 1(2):reviews0002.1–reviews0002.9
4. Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW (2020) TMPRSS2 and COVID-19: serendipity or opportunity for intervention? Cancer Discov. https://doi.org/10.1158/2159-8290.CD-20-0451
5. De Cauwer H, Spaepen A (2020) Are patients with Down syndrome vulnerable to life-threatening COVID-19? Acta Neurol Belg 22:1–3. https://doi.org/10.1007/s13760-020-01373-8
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic Repurposing Approach: New Opportunity for Developing Drugs Against COVID-19;Drug Repurposing for Emerging Infectious Diseases and Cancer;2023
2. Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection;Acta Histochemica;2022-07
3. Clinical characteristics and comorbidities of COVID-19 in unvaccinated patients with Down syndrome: first year report in Brazil;Human Genetics;2022-06-28
4. Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome;Journal of Clinical Medicine;2021-08-23
5. COVID-19 pandemic: what about the gonads?;Hormones;2021-03-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3